Start a New Search
SHOWING 67 RESULTS
The drug ibudilast slowed the brain shrinkage associated with progressive forms of multiple sclerosis in a clinical trial.
University Research | University of RochesterA psychoactive plant called kratom might be a useful tool in the battle to curb opioid addiction, a recent study suggests.
University Research | AAU Universities Battle the Opioid Crisis | Treatment & Prevention | University of RochesterUnsatisfied with existing surgical simulation models, doctors at the University of Rochester developed a process for fabricating lifelike artificial organs, which would allow surgeons to practice complex cases in advance of the actual surgery.
University Research | University of RochesterUniversity of Rochester researchers are using data science and online crowdsourcing to tell whether someone is lying or telling the truth.
University Research | University of RochesterOmar Soufan ’17 and Ibrahim Mohammad ’17 knew from the minute they met three years ago that they were bonded by their pasts—and their future.
University of Rochester | A team of geologists at the University of Rochester has discovered a new species of bird in the Canadian Arctic.
University of RochesterBacteria in the gut, known as the gut microbiome, could be the culprit behind osteoarthritis and joint pain that plagues people who are obese, according to a new study published today in JCI Insight.
University Research | University of RochesterResearchers have found that specific small molecules in blood plasma may be useful in determining whether someone has sustained a mild traumatic brain injury commonly known as a concussion.
Researching the Brain, Seeking Cures | Brain Injury | University Research | University of California, Irvine | University of RochesterSmartphone software and technology can accurately track the severity of Parkinson’s disease symptoms, a new study shows.
University Research | Researching the Brain, Seeking Cures | Parkinson's & Epilepsy | University of RochesterWilmot Cancer Institute patients with advanced melanoma (stage III) now have more options for treatment, thanks to research co-authored by a University of Rochester Medical Center surgical oncologist and published in Lancet Oncology.
University Research | University of Rochester